Staar Surgical's Injector System Approved


The Food and Drug Administration approved Staar Surgical Co.'s (Nasdaq: STAA) injector system for use with implantable lenses to treat cataracts. The stock price leaped $1.26 to $2.75.

About this Entry

This page contains a single entry by published on June 11, 2009 10:44 AM.

UnitedHealth Downgraded was the previous entry in this blog.

American Capital Declares Dividend is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12